- US12612618utility2026Nucleobase Editors Having Reduced Non-target Deamination and Assays for Characterizing Nucleobase Editors0 cites
- US12600971utility2026Modified Immune Cells Having Adenosine Deaminase Base Editors for Modifying a Nucleobase in a Target Sequence0 cites
- US12576151utility2026Fratricide Resistant Modified Immune Cells and Methods of Using the Same0 cites
- US12529041utility2026Compositions and Methods for Delivering a Nucleobase Editing System0 cites
- US12454694utility2025Compositions and Methods for Improving Base Editing0 cites
- US12296053utility2025Nanomaterials Comprising Triols0 cites
- US12268753utility2025Nanomaterials Comprising a Biodegradable Feature0 cites
- US12133884utility2024Methods of Substituting Pathogenic Amino Acids Using Programmable Base Editor Systems0 cites
- US12125145utility2024Systems and Methods for Implemented Mixed Reality in Laboratory Automation0 cites
- US12059477utility2024Nanomaterials0 cites
- US12016908utility2024Compositions and Methods for Treating Hemoglobinopathies0 cites
- US11795443utility2023Uses of Adenosine Base Editors0 cites
- US11752202utility2023Compositions and Methods for Treating Hemoglobinopathies0 cites